Quick Updates On QLT, HNR and PETS

  • Aug 05, 2019 BST
  • Team Kalkine
Quick Updates On QLT, HNR and PETS

Quilter Plc (LSE: QLT)

Quilter PLC (QLT) is a British financial services company engaged in wealth management services and has three most significant offices in London, Southampton and on the Isle of Man. The company's key business operations are Advice & Wealth Management and Wealth Platforms. As on April-13-2018, shares of the company got listed on the main market of the London Stock Exchange for trading. Coronation Asset Management (Pty) Ltd., Prudential Investment Managers (South Africa) (Pty) Ltd., Norges Bank Investment Management and Allan Gray (Pty) Ltd are the major institutional investors in the company. (Source: TR)

Recent Developments

In the exchange filing made by the company as of August 05, 2019, the company announced the sale of its heritage life and pension divisions-Old Mutual Wealth Life Assurance Limited to ReAssure for a total consideration of £425m in cash.

In the exchange filing made by the company as on August 05, 2019, the company reported financial results for the six-months ended June 30, 2019. The group's adjusted profit before tax increased by 5% to £115mn from £110mn recorded in the same period of the corresponding previous financial year. Quinter's adjusted profit before tax increased by 7% to £89m (excluding Quinter Life Assurance). However, Quinter's Life Assurance's adjusted pre-tax profit narrowed marginally to £26m from £27m recorded in the year-ago period.

Operating margin taking consideration of QLA business stood at 29%; however, operating margin excluding the QLA segment stood at 26%. Adjusted diluted earnings per share stood at 5.5 pence in the first half of 2019 and remained flat against the year-ago period. With 4.1 pence contributed from Quinter (excluding its QLA) business and QLA's earnings per share for the period under review stood at 1.4 pence, in line with eps recorded in the year-ago period.

In the period under consideration, the board of the company has announced an interim dividend of 1.7 pence per share.

The group's Asset Under Management during the period recorded a growth of 8% to £118.4 bn against the £109.3 bn recorded in the second half of 2018.

Stock Performance

Daily price chart (as on August 05, 2019), before the market close. (Source: Thomson Reuters)

At the time of writing (before the market close, at 01:56 PM GMT), shares of the QLT were quoting at GBX 137.70 and declined 2.30 points or 1.64% against the previous closing level. Shares of the company have registered a 52weeks high of GBX 156.90 and a 52weeks low of GBX 109.30. On a YTD basis, the stock has delivered a negative price return of 18.32%; however, in the past 5-trading session, the stock declined by approximately 6.42%. At the current trading level, the stock was quoting below its 30-day and 60-day simple moving average prices, though it was trading approximately 5% above its 200-days simple moving average price. The 5-day average daily volume traded in the stock was approximately 32.17% above its 30-day average daily volume traded at the London Stock Exchange.

At the current price, as quoted in the price chart, the dividend yield of the company stood at 2.36%, and the outstanding market capitalisation of the company stood at £2.66bn.

Highlands Natural Resources Plc (LSE: HNR)

The natural resource company Highland Natural Resource is headquartered in the United Kingdom. It is engaged in acquiring oil and gas producing assets and other technologies. As on February-03-2016, the company got listed on the main market of the London Stock Exchange. Sector Investment Managers Ltd. is the major institutional investor in the company.(Source: TR)

Recent Developments

Entered into an agreement to supply hemp-derived Cannabidiol to Cellulac Plc.

In the exchange filing made by the company as of August 02, 2019, the group notified that it has entered into a two year-agreement with Cellulac Plc to supply quality-controlled hemp-derived cannabidiol, containing less than 0.2% Tetrahydrocannabinol.

The supply of hemp-derived cannabidiol will be converted into medical-grade-Cannabidiol, and the finished product will be submitted to Integumen's Labskin test facilities. Integumen will infuse medical-grade-Cannabidiol to their Wound phase and store range of wound care and skincare products.

The Highland's wholly-owned vertically integrated Zoetic's cannabidiol operations in Colorado has already witnessed a triumphant launch of premium CBD consumer products within a month. Also, the natural resource group has identified growth opportunities in the supply of quality control hemp-derived Cannabidiol.

Financial Highlights

In the financial year ended March 31, 2019, the group's revenue from East Denver Oil and Gas Project declined to £1.0m from £2.9m recorded in the year-ago period. However, the group is well-positioned to be benefited from all-eight wells in the FY20.

Pre-tax loss from ordinary activities widened to £5.77mn from £3.97mn recorded in the year-ago period. However, total comprehensive loss during the period decreased to £4.7mn from £5.3mn recorded in the year-ago period, mainly because of £1.06mn gain realised from forex against the loss of £1.34mn realised in the corresponding financial year. Basic and diluted loss per share stood at 4.88 pence against the loss per share of 4.15 pence in the previous year.

Cash flows

Net cash outflow from operation stood at £3.57mn against the outflow of £3.24mn recorded in the year-ago period. Net cash inflow from investing activities was at £2.79mn against the outflow of £5.34mn reported in the previous financial year. Capital expenditure during the FY19 stood at £1.43mn.

Stock Performance

Daily price chart (as on August 05, 2019), before the market close. (Source: Thomson Reuters)

At the time of writing (before the market close, at 01: 59 PM GMT), shares of the HNR were quoting at GBX 7.8 and added 1.30% in day's session. In the year-ago period shares of the company have registered a 52weeks high of GBX 19.80 and a 52weeks low of GBX 6.20 respectively. On a YoY basis, the stock has delivered a negative price return of approximately 60.77%, and on a YTD basis, the stock was down by approximately 29.82% and 15% in the last one months. However, in the last five trading sessions, the stock was up by 4%, mainly on account of 4.69% and 14.18% stock price surge recorded at the LSE as on August 01 and August 02 respectively. At the current trading level, the stock was quoting considerably below its 30-days, 60-days and 200-days simple moving average prices.

At the current price as quoted in the price chart, the outstanding market capitalisation of the company stood at £10.9m.

Pets at Home Group Plc (LSE: PETS)

The United Kingdom-headquartered Pets at Home Group Plc is engaged in the business of retailing pet-food, pet products and pet-related services. As on March-17-2014, its shares got listed on the main market of the London Stock Exchange for trading. Schroder Investment Management Ltd., Merian Global Investors (UK) Ltd., Nordea Bank SA and Norges Bank Investment Management are the major institutional investors in the company.(Source: TR)

Recently, on August 02, 2019, the group recorded its trading update for the first quarter of the FY20, for the 16 weeks ended on July 18, 2019. During the quarter under consideration, retail revenue increased to £266.4mn and recorded a growth of 8.7% on a YoY basis. Vet Group revenue recorded a growth of 18.8% on a YoY basis and stood at £37.0mn. This led to the group's total revenue growth of 9.9% to £303.4mn against the year-ago period. On a like-for-like basis, the group's revenue recorded a growth of 8.0%, and the retail segment and Vet Group segment registered a growth of 8.2% and 6.2% on a like-for-like basis, respectively.

During the period under consideration, the number of customer transaction surged by 5.8% to 18.0mn from 17.0mn recorded in the year-ago period, the number of stores stood at 452 from 449 recorded in the Q1FY19 and number of grooming salons increased to 312 from 310 recorded in the Q1FY19.

Stock Performance

Daily Price Chart (as on August 05, 2019), before the market close. (Source: Thomson Reuters)

At the time of writing (before the market close, at 02:14), shares of the PETS were quoting at GBX 219.4 and added 3.2 points or 1.4% against the previous day closing price. The company's shares have registered a 52weeks high of GBX 229.6 and a 52weeks low of GBX 101.95 respectively. At the current trading, the company's dividend yield stood at 3.4%. On a YTD basis, the stock was up by approximately 86.7% and delivered a price return of 12.43% in the last one month.

Also, at the current trading, the stock was quoting considerably above its 30-days, 60-days and 200-days simple moving average prices, which indicates a long-term uptrend in the stock price. However, 14-day and 9-day RSI level of the stock reflects that the stock has entered an overbought zone.

At the current trading level, the outstanding market capitalisation of the company stood at £1.08bn.

With Bank of England reducing the interest rates to a historic low level, the spotlight is back on diverse investment opportunities. 

Amidst this, are you getting worried about these falling interest rates and wondering where to put your money?

Well! Team Kalkine has a solution for you. You still can earn a relatively stable income by putting money in the dividend-paying stocks.

We think it is the perfect time when you should start accumulating selective dividend stocks to beat the low-interest rates, while we provide a tailored offering in view of valuable stock opportunities and any dividend cut backs to be considered amid scenarios including a prolonged market meltdown.

To know more about these dividend stocks, click here

CLICK HERE FOR YOUR FREE REPORT!
   
x
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK